Ami Asset Management Corp Halozyme Therapeutics, Inc. Transaction History

Ami Asset Management Corp

$1.72 Billion
Q3 2025

A detailed history of Ami Asset Management Corp transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Ami Asset Management Corp holds 12,085 shares of HALO stock, worth $800,027. This represents 0.05% of its overall portfolio holdings.

Number of Shares

12,085

Previous 19,676 38.58%

Holding current value

$800,027

Previous $1.02 Million 13.39%

% of portfolio

0.05%

Previous 0.06%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 16, 2025	SELL	$52.92 - $78.28 $401,715 - $594,223	-7,591 Reduced 38.58%	12,085 $886,000
Q2 2025 Jul 18, 2025	SELL	$47.91 - $70.14 $789,317 - $1.16 Million	-16,475 Reduced 45.57%	19,676 $1.02 Million
Q1 2025 Apr 23, 2025	SELL	$47.74 - $65.16 $62,491 - $85,294	-1,309 Reduced 3.49%	36,151 $2.31 Million
Q4 2024 Jan 16, 2025	SELL	$42.57 - $61.09 $488,873 - $701,557	-11,484 Reduced 23.46%	37,460 $1.79 Million
Q3 2024 Oct 25, 2024	SELL	$51.3 - $64.42 $395,112 - $496,162	-7,702 Reduced 13.6%	48,944 $2.8 Million
Q2 2024 Jul 24, 2024	SELL	$37.81 - $52.4 $3.05 Million - $4.23 Million	-80,744 Reduced 58.77%	56,646 $2.97 Million
Q1 2024 Apr 19, 2024	SELL	$33.68 - $41.95 $190,797 - $237,646	-5,665 Reduced 3.96%	137,390 $5.59 Million
Q4 2023 Jan 19, 2024	SELL	$33.32 - $42.1 $172,697 - $218,204	-5,183 Reduced 3.5%	143,055 $5.29 Million
Q3 2023 Oct 20, 2023	SELL	$36.46 - $44.03 $127,901 - $154,457	-3,508 Reduced 2.31%	148,238 $5.66 Million
Q2 2023 Jul 24, 2023	BUY	$30.28 - $38.74 $188,523 - $241,195	6,226 Added 4.28%	151,746 $5.47 Million
Q1 2023 Apr 20, 2023	BUY	$32.86 - $55.7 $655,162 - $1.11 Million	19,938 Added 15.88%	145,520 $5.56 Million
Q4 2022 Jan 17, 2023	SELL	$40.06 - $59.44 $1,482 - $2,199	-37 Reduced 0.03%	125,582 $7.15 Million
Q3 2022 Oct 24, 2022	SELL	$38.53 - $51.78 $2.69 Million - $3.61 Million	-69,772 Reduced 35.71%	125,619 $4.97 Million
Q2 2022 Jul 21, 2022	SELL	$37.35 - $48.3 $1.98 Million - $2.56 Million	-53,070 Reduced 21.36%	195,391 $8.6 Million
Q1 2022 Apr 27, 2022	BUY	$31.97 - $41.06 $388,755 - $499,289	12,160 Added 5.15%	248,461 $9.91 Million
Q4 2021 Jan 20, 2022	SELL	$31.82 - $40.75 $720,595 - $922,824	-22,646 Reduced 8.75%	236,301 $9.5 Million
Q3 2021 Oct 22, 2021	BUY	$38.47 - $46.42 $345,345 - $416,712	8,977 Added 3.59%	258,947 $10.5 Million
Q2 2021 Jul 20, 2021	BUY	$38.84 - $51.31 $131,861 - $174,197	3,395 Added 1.38%	249,970 $11.4 Million
Q1 2021 Apr 16, 2021	BUY	$39.51 - $51.45 $43,421 - $56,543	1,099 Added 0.45%	246,575 $10.3 Million
Q4 2020 Jan 20, 2021	SELL	$25.81 - $43.62 $7.02 Million - $11.9 Million	-272,050 Reduced 52.57%	245,476 $10.5 Million
Q3 2020 Oct 23, 2020	SELL	$25.74 - $29.63 $228,133 - $262,610	-8,863 Reduced 1.68%	517,526 $13.6 Million
Q2 2020 Jul 15, 2020	BUY	$16.25 - $26.81 $8.55 Million - $14.1 Million	526,389 New	526,389 $14.1 Million

Others Institutions Holding HALO

# of Institutions

631

Shares Held

128M

Call Options Held

408K

Put Options Held

384K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $9.22B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ami Asset Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Ami Asset Management Corp with notifications on news.

Account

Ami Asset Management Corp Halozyme Therapeutics, Inc. Transaction History